HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.

Abstract
The KAI1/CD82 protein has been documented as the tumor metastasis suppressor in many types of human cancers. KAI1/CD82 regulates cell motility and invasiveness; however, the mechanism by which this occurs remains to be fully established. Several studies have shown that KAI1/CD82 modulates integrin-dependent signaling. It was suggested that KAI1/CD82 might function to attenuate the beta1 integrin function of inducing cellular migration. A wound-healing and modified Boyden chamber assays were performed to investigate the mechanism of the KAI1/CD82-mediated inhibition of cell migration. It was found that the migratory ability of H1299/CD82 was inhibited. The immunoblotting and biotinylation assays revealed that H1299/CD82 showed significantly decreased expression of the mature form of beta1, which was functional at the cell surface. It was confirmed that KAI1/CD82 regulates the maturation of the beta1 integrin using CD82-specific si-RNA. These results support a model in which KAI1/CD82 attenuates the maturation of the beta1 integrin precursor and thereby suppresses cell migration.
AuthorsBo Keun Jee, Joo Yong Lee, Young Lim, Kweon Haeng Lee, Yang-Hyeok Jo
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 359 Issue 3 Pg. 703-8 (Aug 03 2007) ISSN: 0006-291X [Print] United States
PMID17560548 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Integrin beta1
  • Kangai-1 Protein
  • RNA, Small Interfering
Topics
  • Animals
  • Cell Line
  • Cell Membrane (metabolism)
  • Cell Movement
  • Gene Expression Regulation, Neoplastic
  • Glycosylation
  • Humans
  • Integrin beta1 (metabolism)
  • Kangai-1 Protein (genetics, metabolism)
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Mice
  • Protein Processing, Post-Translational
  • RNA, Small Interfering (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: